Hamza Mostafa

Dr. Hamza Mostafa

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Clinica Chimica Acta
Verified
Journal Article
Open access
AAArwa M. Amin
Arwa M. Amin
Hamza MostafaHamza Mostafa
Hamza Mostafa
HKHani M.J. Khojah
Hani M.J. Khojah
Alzheimer's disease (AD) is a neurodegenerative disease with significant socioeconomic burden worldwide. Although genetics and environmental factors play a role, AD is highly associated with insulin resistance (IR) disorders such as metabolic syndrome (MS), obesity, and type two diabetes mellitus (T2DM). These findings highlight a shared pathogenesis. The use of metabolomics as a downstream systems' biology (omics) approach can help to identify these shared metabolic traits and assist in the early identification of at-risk groups and potentially guide therapy. Targeting the shared AD-IR metabolic trait with lifestyle interventions and pharmacological treatments may offer promising AD therapeutic approach. In this narrative review, we reviewed the literature on the AD-IR pathogenic link, the shared genetics and metabolomics biomarkers between AD and IR disorders, as well as the lifestyle interventions and pharmacological treatments which target this pathogenic link.

1 May 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AAArwa M. Amin
Arwa M. Amin
LCLim Sheau Chin
Lim Sheau Chin
CTChin-Hoe Teh
Chin-Hoe Teh
Hamza MostafaHamza Mostafa
Hamza Mostafa
DNDzul Azri Mohamed Noor
Dzul Azri Mohamed Noor
BIBaharudin Ibrahim
Baharudin Ibrahim

1 June 2017 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
Hamza MostafaHamza Mostafa
Hamza Mostafa
AAArwa M. Amin
Arwa M. Amin
CTChin-Hoe Teh
Chin-Hoe Teh
VMVikneswaran A/L Murugaiyah
Vikneswaran A/L Murugaiyah
NANor Hayati Arif
Nor Hayati Arif
BIBaharudin Ibrahim
Baharudin Ibrahim

12 December 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Hamza MostafaHamza Mostafa
Hamza Mostafa
IBInken Behrendt
Inken Behrendt
TMTomas Meroño
Tomas Meroño
Raúl González-DomínguezRaúl González-Domínguez
Raúl González-Domínguez
MFMathias Fasshauer
Mathias Fasshauer
SKSabine Kuntz
Sabine Kuntz
Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment.

28 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Hamza MostafaHamza Mostafa
Hamza Mostafa
TMTomas Meroño
Tomas Meroño
AMAntonio Miñarro
Antonio Miñarro
ASAlex Sánchez-Pla
Alex Sánchez-Pla
FLFabián Lanuza
Fabián Lanuza
CACristina Andrés-Lacueva
Cristina Andrés-Lacueva
Anthocyanins (ACNs) are (poly)phenols associated with reduced cardiometabolic risk. Associations between dietary intake, microbial metabolism, and cardiometabolic health benefits of ACNs have not been fully characterized. Our aims were to study the association between ACN intake, considering its dietary sources, and plasma metabolites, and to relate them with cardiometabolic risk factors in an observational study. A total of 1351 samples from 624 participants (55% female, mean age: 45 ± 12 years old) enrolled in the DCH-NG MAX study were studied using a targeted metabolomic analysis. Twenty-four-hour dietary recalls were used to collect dietary data at baseline, six, and twelve months. ACN content of foods was calculated using Phenol Explorer and foods were categorized into food groups. The median intake of total ACNs was 1.6mg/day. Using mixed graphical models, ACNs from different foods showed specific associations with plasma metabolome biomarkers. Combining these results with censored regression analysis, metabolites associated with ACNs intake were: salsolinol sulfate, 4-methylcatechol sulfate, linoleoyl carnitine, 3,4-dihydroxyphenylacetic acid, and one valerolactone. Salsolinol sulfate and 4-methylcatechol sulfate, both related to the intake of ACNs mainly from berries, were inversely associated with visceral adipose tissue. In conclusion, plasma metabolome biomarkers of dietary ACNs depended on the dietary source and some of them, such as salsolinol sulfate and 4-methylcatechol sulfate may link berry intake with cardiometabolic health benefits.